Glycopyrronium Verisfield (Glycopyrronium Bromide)

Glycopyrronium Verisfield is indicated for the management of several conditions where airway constriction or excessive secretions are problematic.

• Chronic obstructive pulmonary disease (COPD) to improve lung function and reduce exacerbations.
• Asthma as an add‑on therapy for patients with persistent symptoms despite other treatments.
• Hyperhidrosis (excessive sweating) to reduce sweat production in affected areas.
• Pre‑operative reduction of airway secretions in certain surgical contexts.
• Off‑label use in research settings for studying muscarinic receptor antagonism.

The safety profile of Glycopyrronium Verisfield reflects its anticholinergic activity, with side effects ranging from mild to potentially serious.

Common

• Dry mouth.
• Constipation.
• Urinary retention.
• Blurred vision.
• Headache.
• Altered taste perception.

Serious

• Severe allergic reaction (anaphylaxis).
• Tachycardia or other cardiac arrhythmias.
• Acute angle‑closure glaucoma.
• Paradoxical bronchospasm.
• Severe urinary retention requiring catheterisation.
• Significant hypotension.

Before starting Glycopyrronium Verisfield, healthcare providers should evaluate several precautionary factors to ensure safe use.

• Known hypersensitivity to glycopyrronium bromide or other anticholinergic agents.
• History of narrow‑angle glaucoma.
• Significant urinary retention or prostate enlargement.
• Underlying cardiovascular disease, especially arrhythmias or tachycardia.
• Severe hepatic impairment.
• Pregnancy or breastfeeding status (risk not established).
• Use in pediatric patients (safety not established).

Glycopyrronium Verisfield may interact with other medicines that affect cholinergic pathways or cardiac function.

Avoid

• Other anticholinergic agents (e.g., ipratropium, atropine) – additive anticholinergic effects.
• Monoamine oxidase inhibitors (MAOIs) – potential for hypertensive crisis.
• β‑agonists – may blunt bronchodilator response.

Use with caution

• Drugs that prolong QT interval (e.g., certain antiarrhythmics) – increased risk of arrhythmia.
• Antihistamines with anticholinergic properties – enhanced side effects.
• Diuretics – may exacerbate dry mouth and electrolyte imbalance.
• Opioids – risk of urinary retention.
• Other respiratory medications – monitor for additive effects.